Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 13 studies | 28% ± 13% | |
| epithelial cell | 12 studies | 35% ± 16% | |
| secretory cell | 7 studies | 24% ± 8% | |
| renal alpha-intercalated cell | 7 studies | 50% ± 20% | |
| goblet cell | 7 studies | 33% ± 11% | |
| transit amplifying cell | 6 studies | 30% ± 10% | |
| ciliated cell | 6 studies | 32% ± 10% | |
| brush cell | 5 studies | 36% ± 6% | |
| type I pneumocyte | 4 studies | 21% ± 3% | |
| enterocyte | 4 studies | 25% ± 6% | |
| intestinal crypt stem cell | 4 studies | 30% ± 4% | |
| ionocyte | 3 studies | 44% ± 3% | |
| pancreatic A cell | 3 studies | 32% ± 17% | |
| progenitor cell | 3 studies | 28% ± 6% | |
| acinar cell | 3 studies | 40% ± 20% | |
| mesothelial cell | 3 studies | 29% ± 16% | |
| pancreatic ductal cell | 3 studies | 57% ± 23% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 3 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 2830.53 | 328 / 328 | 97% | 116.55 | 172 / 178 |
| breast | 100% | 5523.75 | 459 / 459 | 95% | 107.75 | 1059 / 1118 |
| thymus | 100% | 2789.35 | 652 / 653 | 94% | 88.40 | 569 / 605 |
| ovary | 97% | 2017.19 | 174 / 180 | 97% | 97.27 | 418 / 430 |
| kidney | 100% | 2907.16 | 89 / 89 | 89% | 98.43 | 801 / 901 |
| prostate | 89% | 1766.79 | 218 / 245 | 92% | 76.43 | 462 / 502 |
| lung | 79% | 1238.99 | 458 / 578 | 97% | 157.40 | 1122 / 1155 |
| stomach | 78% | 3072.97 | 279 / 359 | 96% | 186.36 | 275 / 286 |
| intestine | 64% | 5558.93 | 615 / 966 | 99% | 192.71 | 522 / 527 |
| bladder | 67% | 3383.67 | 14 / 21 | 92% | 124.24 | 465 / 504 |
| esophagus | 47% | 730.17 | 678 / 1445 | 99% | 192.49 | 181 / 183 |
| uterus | 45% | 358.85 | 76 / 170 | 87% | 98.13 | 399 / 459 |
| liver | 90% | 929.57 | 204 / 226 | 31% | 26.04 | 125 / 406 |
| skin | 72% | 1252.36 | 1305 / 1809 | 29% | 18.10 | 135 / 472 |
| ureter | 0% | 0 | 0 / 0 | 100% | 48.37 | 1 / 1 |
| adipose | 99% | 3797.51 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 109.74 | 42 / 45 |
| heart | 89% | 2535.05 | 762 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 13% | 93.98 | 34 / 258 | 8% | 4.04 | 19 / 230 |
| peripheral blood | 17% | 625.39 | 162 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 10% | 90.44 | 137 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 10% | 3.15 | 8 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 2.93 | 2 / 29 |
| muscle | 2% | 13.67 | 19 / 803 | 0% | 0 | 0 / 0 |
| brain | 1% | 5.31 | 21 / 2642 | 1% | 0.45 | 9 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0003165 | Biological process | Purkinje myocyte development |
| GO_0007155 | Biological process | cell adhesion |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0002934 | Biological process | desmosome organization |
| GO_0086091 | Biological process | regulation of heart rate by cardiac conduction |
| GO_0098911 | Biological process | regulation of ventricular cardiac muscle cell action potential |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0032570 | Biological process | response to progesterone |
| GO_0086073 | Biological process | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO_0060135 | Biological process | maternal process involved in female pregnancy |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0001533 | Cellular component | cornified envelope |
| GO_0005911 | Cellular component | cell-cell junction |
| GO_0009986 | Cellular component | cell surface |
| GO_0016328 | Cellular component | lateral plasma membrane |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0030054 | Cellular component | cell junction |
| GO_0030057 | Cellular component | desmosome |
| GO_0014704 | Cellular component | intercalated disc |
| GO_0086083 | Molecular function | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
| GO_0050839 | Molecular function | cell adhesion molecule binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DSG2 |
| Protein name | Desmoglein-2 (Cadherin family member 5) (HDGC) Desmoglein 2 |
| Synonyms | CDHF5 |
| Description | FUNCTION: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion. |
| Accessions | A0A804HJQ3 ENST00000261590.13 ENST00000585206.1 A0A804HIA2 J3KSI6 ENST00000683654.1 Q14126 ENST00000682241.2 Q8WWR7 |